^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    COMPANY:
    University of Chicago

    i
    Other names: Univ. of Chicago | University of Chicago | U of C | Uchicago | Pritzker School of Medicine
    Related tests:
    Evidence
    News
    12d
    A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies. (clinicaltrials.gov)
    P1/2 | N=24 | Not yet recruiting | Sponsor: University of Chicago
    New P1/2 trial
    |
    PD-L1 (Programmed death ligand 1) • BRAF (B-raf proto-oncogene) • ER (Estrogen receptor) • ALK (Anaplastic lymphoma kinase) • ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS) • CTAG1B (Cancer/testis antigen 1B)
    |
    cyclophosphamide • decitabine • Proleukin (aldesleukin)